NovaBay Pharmaceuticals, Inc. / Stablecoin Development Corporation Overview
Pro stress-test →NovaBay Pharmaceuticals announced in March 2026 a complete strategic pivot, changing its name to Stablecoin Development Corporation and its ticker symbol to SDEV. The company has realigned as an on-chain holding company focused on protocol-aligned digital assets within the Sky protocol ecosystem. This represents a fundamental shift from the company's historical focus on healthcare and wound care products.
Strategic Profile
Pro stress-test →Following a $134 million private placement in January 2026, NovaBay completed its pivot to crypto, building a large position in SKY tokens and holding around 2.06 billion tokens. The firm has begun staking its SKY holdings to earn rewards, reporting around 26.6 million SKY tokens earned to date. The company transitioned from a struggling pharmaceutical/wound-care business to a digital asset holding company focused on stablecoin infrastructure.
Competitive Landscape
Pro stress-test →As a holding company in the stablecoin/digital asset space, NovaBay/SDEV now competes within decentralized finance infrastructure rather than pharmaceuticals. Key competitors would include other crypto-focused public market vehicles, DeFi protocols, and stablecoin infrastructure providers. The company's large SKY token position aligns it with Sky protocol governance and economics.
Industry Context
NovaBay Pharmaceuticals, Inc. / Stablecoin Development Corporation operates in Stablecoin infrastructure and DeFi holding companies.
Key facts
Founded: 1981 · Headquarters: Emeryville, US · Employees: N/A · Revenue: N/A · Market cap: N/A